🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
40 STEMI patients who underwent primary PCI were subsequently allocated int...
Status
Completed
Location
RSUD Dr Moewardi
Start Date
2024-09-01
Trial ID
NCT06871358
Treatments Being Tested
The study is a multi-centre, Open-label, Randomized Controlled, 1:1 trial c...
Status
Recruiting
Location
Imelda Bonheiden
Start Date
2022-07-22
Trial ID
NCT05491200
XIENCE 90 study is a prospective, single arm, multi-center, open label tria...
Status
Completed
Location
Huntsville Hospital (Heart Center Research LLC)
Start Date
2017-07-19
Trial ID
NCT03218787
Dual antiplatelet therapy (DAPT) with low-dose aspirin and a P2Y12 inhibito...
Status
Recruiting
Location
University of Florida
Start Date
2025-03-10
Trial ID
NCT06821191
Treatments Being Tested
The purpose of this study is to evaluate the safety of reducing dual antipl...
Status
Unknown
Location
Kyoto University Graduate School of Medicine
Start Date
2018-04-02
Trial ID
NCT03462498
Treatments Being Tested
Rationale: Heart attacks are a major cause of death and result from coronar...
Status
Recruiting
Location
Aalborg University Hospital
Start Date
2022-06-17
Trial ID
NCT05262803
Treatments Being Tested
The optimal antithrombotic management in patients with coronary artery dise...
Status
Recruiting
Location
ASZ Aalst
Start Date
2023-01-11
Trial ID
NCT04436978
Treatments Being Tested
It is not uncommon that patients requiring dual antiplatelet therapy (DAPT)...
Status
Completed
Location
University of Florida
Start Date
2016-03
Trial ID
NCT02567461
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of a rout...
Status
Withdrawn
Location
Kaiser Franz Josef Hospital
Start Date
TBD
Trial ID
NCT02974777
Treatments Being Tested
This study is aimed at making a comparison of the safety and efficacy of st...
Status
Recruiting
Location
Beijing Anzhen Hospital, Capital Medical University
Start Date
2023-10-30
Trial ID
NCT06090890
Treatments Being Tested